Skip to main content
. Author manuscript; available in PMC: 2017 Nov 16.
Published in final edited form as: Toxicol Lett. 2016 Sep 19;262:92–99. doi: 10.1016/j.toxlet.2016.09.011

Fig. 4.

Fig. 4

3T3-L1 cells were pretreated with Rimonabant (0.1, 0.2, or 0.5 μM) or vehicle (DMSO) for two hours. Then, the cells were induced to differentiate in the presence of AEA (10 μM), butylparaben (50 μM) or benzylparaben (50 μM), while maintained in rimonabant for 7 days. (A) Increasing concentrations of rimonabant had no effect on paraben-enhanced adipocyte differentiation as measured by oil red O. (B) Effects of rimonabant on parabens-mediated upregulation of adipocyte marker PPARγ, C/EBPα, and FABP4. The dark triangles indicate the increasing doses of rimonabant shown in (A). *p < 0.05 compared with the control (0 μM of rimonabant) within each treatment group. NS, not significant.